Amalgent Therapeutics, Inc.

Greenville, NC

UEI
CP5VN4N2MXX3
CAGE
8J8D6
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
300 E 1st St, Greenville, NC 27858, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Amalgent Therapeutics, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Mechanism and efficacy of a novel opioid adjuvant - project summary managing the complex risk-benefit profile of… Grant · R43DA059522 National Institute on Drug Abuse $220,668
Development of an opioid sparing therapeutic to minimize opioid use disorderand tolerance in the treatment of pain -… Grant · R44DA059302 National Institute on Drug Abuse $2,579,875

Quick answers

What is Amalgent Therapeutics, Inc.'s UEI?

Amalgent Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is CP5VN4N2MXX3.

What is Amalgent Therapeutics, Inc.'s CAGE code?

Amalgent Therapeutics, Inc.'s CAGE code is 8J8D6.

Where is Amalgent Therapeutics, Inc. located?

Amalgent Therapeutics, Inc.'s physical address in SAM.gov is 300 E 1st St, Greenville, NC 27858, USA.

Is Amalgent Therapeutics, Inc. registered in SAM.gov?

Yes. Amalgent Therapeutics, Inc.'s SAM.gov registration is active through September 8, 2027.

What is Amalgent Therapeutics, Inc.'s most recent federal award?

Amalgent Therapeutics, Inc.'s most recent federal grant award is Mechanism and efficacy of a novel opioid adjuvant - project summary managing the complex risk-benefit profile of… (R43DA059522), from National Institute on Drug Abuse, on August 1, 2024.

On GovTribe

See Amalgent Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login